Peptide Reference
P-21
P-21 Peptide
A nootropic peptide developed from cerebrolysin that enhances cognitive function, neurogenesis, and neuroplasticity.
Status
research
Category
cognitive
Typical cost
$80-150/vial (5mg)
Mechanism
Promotes neurogenesis and synaptic plasticity. Enhances learning and memory formation. Supports neuronal repair and cognitive function.
Potential benefits
- Enhanced learning
- Improved memory
- Neurogenesis support
- Better focus
- Cognitive enhancement
Reported side effects
- Limited human data
- Headache
- Mild stimulation
Common dosing references
subcutaneous
100-300mcg · Daily
4-8 weeks
intranasal
50-100mcg · Daily
4-8 weeks
Research notes
P-21 and cognitive enhancement
2012
Demonstrated enhanced neurogenesis and cognitive function in animal models
Regulatory and sourcing notes
Research chemical only. Not FDA-approved. Experimental nootropic.
Research peptide. Limited availability. Derived from cerebrolysin research.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides